1 This study examined the eects of chronic exposure of rats to 3,4-methylenedioxymethamphetamine (MDMA) on [ 6 These results show, for the ®rst time, an altered responsiveness of vascular tissue to MDMA after chronic administration. In addition, they demonstrate a dierence in the sensitivity of central and peripheral 5-HT uptake systems to chronic MDMA exposure, and suggest that the action of MDMA in the cardiovascular system does not arise from a direct eect of MDMA on peripheral 5-HT transport.
Introduction
Much of the research to date on the psychoactive ringsubstituted amphetamine 3,4-methylenedioxymethamphetamine (MDMA) has focused on its neurotoxic eects, arising from its use as the recreational drug,`Ecstasy'. Acute eects of MDMA in the central nervous system include release of 5-hydroxytryptamine (5-HT; Nichols et al., 1982; McKenna et al., 1991) and an increase in the CSF levels of 5-HT and its major metabolite 5-hydroxyindoleacetic acid (5-HIAA) in man (Ricaurte et al., 1990) . In addition, MDMA irreversibly inhibits tryptophan hydroxylase (TPH), the rate-limiting enzyme of 5-HT synthesis (Schmidt & Taylor, 1987) . MDMA targets both plasma membrane and vesicular 5-HT transporters, and induces 5-HT release via MDMA ± 5-HT heteroexchange (Hekmatpanah & Peroutka, 1990; Rudnick & Wall, 1992) . Furthermore, Bengel et al. (1998) have shown that in 5-HT transporter-de®cient mice, MDMA-induced hyperactivity is not observed.
In the cardiovascular system, relatively little is known regarding the in¯uence of MDMA on vascular function, although there are reports of adverse cardiac eects in humans. These include the induction of arrhythmias (Dowling et al., 1987; Milroy et al., 1996) and sudden cardiac death (Suarez & Riemersma, 1988) . Common non-fatal consequences of MDMA ingestion in humans include ventricular tachycardia, hypertension (Hayner & McKinney, 1986; Vollenweider et al., 1998 , Mas et al., 1999 and impaired parasympathetic activity (Brody et al., 1998) , suggestive of enhanced sympathetic tone. In rats, reported cardiovascular actions of MDMA include arrhythmogenic eects in isolated perfused hearts (Fitzgerald & Reid, 1994) and elevations of both temperature and heart rate (Gordon et al., 1991 (Gordon et al., ).1999 ) and at central a 2 -adrenoceptors mediating depressor responses (McDaid & Docherty, 2001) .
Recreational abuse of MDMA often occurs in the context of chronic exposure, thus there is a need to understand fully the long-term consequences of MDMA administration in a wide-range of 5-HT-associated systems. A prolonged reduction in [ 3 H]5-HT uptake in the brain following chronic exposure to MDMA is well-documented (Cummins, 1986; Sabol et al., 1996) , yet there is little information on how peripheral functions of 5-HT are altered by MDMA. Unlike in the brain, repeated injections of MDMA to rats (twice daily for 4 days) had no signi®cant eect on platelet 5-HT uptake sites 7 days later (Nash et al., 1991) , from which it can be concluded that brain and peripheral 5-HT transporters dier in their sensitivity to MDMA. It is not known whether the extraneuronal 5-HT uptake sites in rat aorta, identi®ed by Fukuda et al. (1986) , are aected by MDMA. There is also no information on whether vascular responses to 5-HT are altered by chronic exposure to MDMA.
In this study, we have compared the eects of chronic administration of MDMA (20 mg kg
71
, twice daily for 4 days) on central and vascular 5-HT uptake, and on vascular responses to 5-HT, using the rat as an experimental model.
Methods

Animals
During and after treatments, male Wistar rats weighing 240 ± 260 g were housed separately at room temperature under a 12 h light/dark cycle with food and water in open supply. Between three and ®ve animals were used for each set of experiments, and brain synaptosomes and vascular tissue were obtained or prepared, respectively, from dierent animals.
Synthesis and purification of MDMA Synthesis of MDMA.HCl was carried out following the method of Braun et al. (1980) . Brie¯y, isosafrole was oxidized to 3,4-methylenedioxyphenylacetone, which was then reacted with methylamine. The product of this reaction was treated with sodium cyanoborohydride to yield the corresponding MDMA derivative. This product was prepared as its (+)-HCl salt and its structure con®rmed by NMR, microanalysis and mass spectroscopy. All doses and concentrations of MDMA used in the study refer to the HCl salt.
Drug administration
Chronic treatment with MDMA MDMA (20 mg kg
71
, dissolved in 1 ml 0.9% saline) was administered eight times (i.p.) in total (twice daily for 4 consecutive days). Animals were allowed to recover for periods of 1, 7, 14 or 21 days after the last dose, before tissue isolation. Control rats were injected with 1 ml of 0.9% saline at the same times that the experimental animals received MDMA and were held in the same manner.
Direct administration of MDMA Addition of MDMA (100 mM, ®nal concentration) was made to the incubation mixture of the synaptosomal and aortic uptake experiments 10 min prior to initiation of each assay. MDMA was present in the incubation mixture for the duration of each assay: 4 min (synaptosomes) or 5 min (aortic rings).
Synaptosomal uptake procedure
Saline-and MDMA-treated animals were killed by cervical dislocation; brains were rapidly removed and placed in icecold homogenization medium containing 0.32 M sucrose, 1 mM EDTA and 0.25 mM dithiothreitol. Following homogenization of the whole brain, the synaptosomal fraction was puri®ed by Percoll density gradient centrifugation according to the method of Dunkley et al. (1988) . The synaptosomal fraction (layer 4) was removed using a Pasteur pipette, washed twice in ice-cold Krebs' bicarbonate medium (composition mM): NaCl 109. , diluted with unlabelled 5-HT to give a ®nal concentration range of 1 ± 500 nM 5-HT). Uptake of [ 3 H]5-HT was determined in triplicate at each concentration of the substrate, and transport was linear between 0 ± 20 min at 378C. A 4 min incubation period was used for all subsequent experiments. Transport assays were terminated by addition of an excess of ice-cold 5-HT and placement of the tubes on ice followed by centrifugation at 16,0006g for 10 min at 48C. The results are expressed as the rate of speci®c uptake of 5-HT (pmol mg protein 71 min
71
), which was obtained by subtraction of the non-speci®c transport (de®ned using 100 mM alaproclate) from the total transport. Separate experiments determined that sodium-independent transport was less than the non-speci®c transport de®ned by alaproclate. Protein was determined by the method of Markwell et al. (1978 Fukuda et al. (1986) , with minor modi®cations. Brie¯y, thoracic aortic segments, 40 mm in length, were incubated in Krebs' bicarbonate medium containing 0.1 mM pargyline for 30 min at 258C. After rinsing in fresh Krebs' medium, segments of 3 mm were prepared, which were then placed in individual tubes in a ®nal volume of 250 ml Krebs' medium at 378C in a shaking water bath. After equilibration of the rings for 5 min, uptake of [ ) and the incubation was continued for an additional 5 min. The assay was terminated by removing the rings from the incubation medium, and blotting them between pieces of ®lter paper. Each ring was extracted in 4 ml of scintillation¯uid for 48 h in the dark, and the quantity of radioactivity measured by liquid scintillation spectroscopy. Transport was determined in both normal Krebs' and sodium-free medium, and the quantity of sodium-dependent uptake determined by subtraction. Previous work has shown both sodium-dependent and -independent uptake of [ 3 H]5-HT (0.1 ± 9 mM) in aortic rings (Fukuda et al., 1986) , and a concentration of 1 mM was selected for these experiments. The results are expressed as the sodium-dependent transport of 5-HT (nmol [ 
Measurement of aortic contraction
Descending thoracic aortae were dissected, mounted in a tissue bath, attached to a Grass force displacement (FT03) transducer and maintained at 378C (Figure 1 ). There was no signi®cant dierence in the K m (substrate concentration required for half maximal rate of uptake) for 5-HT transport between MDMA-and salinetreated animals at any of the time points tested.
The effect of chronic MDMA treatment on 5-HT-induced rat aortic ring contraction
Chronic MDMA treatment signi®cantly reduced the maximum contraction induced by 5-HT (E max ) in aortae isolated 1 and 7 days after treatment (0.51+0.05 g; 1.18+0.07 g respectively), compared to saline-treated controls (0.78+0.03 g; 1.49+0.06 g, P50.01 in each case). However the EC 50 was not signi®cantly altered, 1 and 7 days after treatment (3.51+1.69 mM; 3.61+0.99 mM respectively), compared to saline-treated controls (1.56+0.42 mM; 2.98+0.62 mM). At 14 and 21 days post treatment, neither E max nor EC 50 values for 5-HT were signi®cantly dierent from saline-treated controls (Figure 2A ± D) .
Investigation of the effect of chronic MDMA treatment on transport of [ Figure 3A ). The reduction in whole brain synaptosomal uptake of [ 3 H]5-HT (100 nM) after chronic administration of MDMA is also shown in Figure  3B for comparative purposes (14+2% of saline-treated animals). 
Discussion
This study con®rms the view that 5-HT transport is one of the primary targets for MDMA action in the brain. After 21 days, the transport of 5-HT into synaptosomes prepared following chronic MDMA treatment remained signi®cantly depressed, at 76% of control values. This is close to the level at which 5-HT transport remained 21 days after a single i.p. dose of the drug (20 mg kg
71
; results not shown), which is an indication of the severity that even a`once-o' challenge with MDMA may have on 5-HT transport in the rat brain.
The dose of MDMA administered in the present study compares well with other administration protocols that have been shown to result in neurodegeneration together with a range of associated behavioural and physiological changes (Esteban et al., 2001; O'Loinsigh et al., 2001 ). While we have not measured brain levels of MDMA after chronic administration, we have previously determined the concentration dependence of MDMA eects on cerebral 5-HT transport in vitro, and found the IC 50 to be in the low micromolar range, with a maximal inhibition of uptake occurring at 100 mM MDMA (results not shown). This responsiveness to MDMA corresponds well with the estimate that a brain concentration of 11 ± 20 mM MDMA would arise from a dose of 10 ± 15 mg kg 71 i.p. (Esteban et al., 2001) . The mechanism by which chronic MDMA treatment results in reduced 5-HT responsiveness in vasculature is unclear. It does not appear that MDMA increases plasma levels of 5-HT, thereby exposing vascular 5-HT receptors to a chronic stimulus and receptor down-regulation, since no evidence was found for reduced [ 3 H]5-HT re-uptake into aorta. Similarly, an MDMA-induced reduction in platelet uptake of 5-HT is thought unlikely, since rat platelets are reportedly much less sensitive than the cerebral cortex to the (Nash et al., 1991) . Few studies have examined the long-term eect of MDMA treatment on the subsequent response to 5-HT agonist challenge. However, both Grano & Ashby (2001) and Poland (1990) have shown altered 5-HT 1A receptor-mediated responses in the peripheral nervous system after MDMA. This shows that such changes can occur in both the CNS and the periphery.
An obvious question is whether metabolism of chronicallyadministered MDMA generates compounds that target 5-HTmediated responses in the vascular system. While this has not been tested in the present study, a number of novel amphetamine derivatives, structurally related to MDMA, have recently been found to reduce vascular responses to 5-HT in direct experiments in vitro (Murphy et al., 2001) , suggesting the possibility that modi®cation of the MDMA structure changes its bioactivity pro®le. It should also be noted that route of administration, as well as species, strain and sex dierences (Chu et al., 1996) could potentially in¯uence the mechanism and extent of MDMA metabolism.
Increasing evidence implicates MDMA-induced generation of free radicals and subsequent oxidative stress in MDMAinduced neurodegeneration (Bai et al., 2001; Colado et al., 1997) . Formation of such species in the periphery could in principle contribute to compromised 5-HT receptor function in vasculature and 5-HT transporter dysfunction centrally.
Further studies will be required to demonstrate conclusively that MDMA modulates 5-HT responses in vasculature and brain by the same or dierent mechanisms. However, we can conclude that MDMA compromises vascular function, and although we have not presented de®nitive evidence for longer term damage, downstream events ensuing from those observed in the vasculature may well cause more lasting eects.
In summary, this study con®rms that chronic exposure of rat brain to MDMA causes a severe and long-lasting depletion in the capacity of the 5-HT transporter to take up and therefore inactivate 5-HT. In addition, MDMA produces a reduced capacity of the aorta to contract in the presence of 5-HT. Thus, the long-term eects of MDMA on the 5-HT system extend far beyond its primary site of action. These results therefore serve to underline the potential dangers that may arise from abuse of MDMA in humans. 
